Brexit: Phased Process for implementing Medicines Regulation in Northern Ireland
Recommendation

1/2 December 2026
How to implement EU-GMP Chapter 8
A video conference of the Ireland/Northern Ireland Specialised Committee was held early November exchanging updates on the implementation of the so called Northern Ireland Protocol. The meeting was co-chaired by officials from the UK Government and the EU Commission. Part of the UK delegation also was a representative from the Northern Ireland Executive.
The Committee noted that "an agreed approach had been reached on a phased process for implementing medicines regulation in Northern Ireland up to 31 December 2021, providing the additional time needed for businesses to prepare in relation to batch testing, importation and Falsified Medicines Directive requirements".
Agreement has also been reached on the process for identifying Northern Ireland traders for VAT purposes; for transit procedures and on the elements of the Electricity Directive.
Source: UK Government Press Release "Ireland/Northern Ireland Specialised Committee 05 November 2020".
Related GMP News
02.11.2026Singapore Added to the List of Recognised third Countries for Importation of APIs
02.11.2026Failed GMP Training in 2026: Further GMP Training Deficiencies in FDA Warning Letters
21.10.2026Switzerland: GMP Compliance by Foreign Manufacturers
14.10.2026EU Pharma Package: Council Adopts New Rules
14.10.2026ICH Publishes New Training Material for Quality Guidelines
14.10.2026WHO issues Draft Guidance on Quality Risk Management


